glp-1 supply shortage news november 2025 Nutritional Support Market Size & Share 2025-2035 GLP-1 receptor agonist shortage expected

Flexibility matters

Table 1 summarizes some nasal delivery devices with a brief description of the principles, dosage form, and limitations

GLP-1 agonists and DPP-4 inhibitors were the sole antihyperglycemic agents reported in 46.6% and 25.4% of the cases, respectively

Themes continuing from 2025 into 2026 As the obesity market moves into its acceleration phase, several trends that gained traction in 2025 will continue to influence strategies and market dynamics in 2026: As the obesity market evolves, there is a growing recognition that use of obesity medications to maintain weight will be critical for many people

& Garraway, S